SXI Life Sciences
7.474,53
PKT
-41,24
PKT
-0,55
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
31.05.16 | Roche overweight | Morgan Stanley | |
31.05.16 | Novartis Underweight | Morgan Stanley | |
31.05.16 | Roche overweight | JP Morgan Chase & Co. | |
31.05.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
23.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
23.05.16 | Novartis Neutral | Citigroup Corp. | |
19.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
19.05.16 | Roche overweight | JP Morgan Chase & Co. | |
18.05.16 | Novartis Underweight | Morgan Stanley | |
18.05.16 | Novartis Neutral | Citigroup Corp. | |
11.05.16 | Novartis buy | Jefferies & Company Inc. | |
11.05.16 | Roche buy | Jefferies & Company Inc. | |
09.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
28.04.16 | Novartis Neutral | UBS AG | |
26.04.16 | Novartis Outperform | Bernstein Research | |
26.04.16 | Roche Outperform | Bernstein Research | |
26.04.16 | Novartis buy | HSBC | |
26.04.16 | Novartis Neutral | BNP PARIBAS | |
25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
22.04.16 | Novartis Underweight | Morgan Stanley | |
22.04.16 | Novartis Equal weight | Barclays Capital | |
21.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
20.04.16 | Roche overweight | Morgan Stanley | |
20.04.16 | Roche overweight | JP Morgan Chase & Co. | |
20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
19.04.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
18.04.16 | Roche buy | UBS AG | |
15.04.16 | Novartis Neutral | UBS AG | |
14.04.16 | Novartis Underweight | Barclays Capital | |
13.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
12.04.16 | Roche overweight | JP Morgan Chase & Co. | |
12.04.16 | Novartis Underweight | Morgan Stanley | |
12.04.16 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
06.04.16 | Novartis Hold | Société Générale Group S.A. (SG) | |
05.04.16 | Roche overweight | Morgan Stanley | |
05.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
01.04.16 | Roche overweight | JP Morgan Chase & Co. | |
01.04.16 | Novartis Neutral | UBS AG |